To summarise, coagulation (as measured by plasma levels of protein C) and fibrinolysis (as measured by plasma levels of PAI-1) have been shown to be markedly abnormal in COVID-19 and have been independently associated with adverse clinical outcomes. This evidence concerns the gene SERPINE1 and COVID-19.